The company will permit six generic drugmakers to make and sell lenacapavir in 120 countries that have high incidence of the disease, but limited resources.
Low interest financing, sweet lease deals and free charging boosted Tesla's global deliveries in the third quarter, the first increase this year for the electric vehicle maker.